| Income Statement |
| Operating Expenses | 12.27M |
|
| Research and Development Expense | 9.52M |
| Selling, General and Administrative Expense | 2.74M |
| Operating Income | -12.27M |
| Net Income | -11.73M |
| Net Income Common Stock | -11.73M |
| Net Income Common Stock (USD) | -11.73M |
| Consolidated Income | -11.73M |
| Earnings per Basic Share | -1.28 |
| Earnings per Basic Share (USD) | -1.28 |
| Earnings per Diluted Share | -1.28 |
| Earning Before Interest & Taxes (EBIT) | -11.73M |
| Earning Before Interest & Taxes (USD) | -11.73M |
| Weighted Average Shares | 9.14M |
| Weighted Average Shares Diluted | 9.14M |
| Balance Sheet |
| Cash and Equivalents | 53.43M |
| Cash and Equivalents (USD) | 53.43M |
| Investments | 33.75K |
| Investments Current | 33.75K |
| Current Assets | 56.69M |
| Total Assets | 56.69M |
| Current Liabilities | 7.22M |
| Total Liabilities | 7.29M |
| Accumulated Retained Earnings (Deficit) | -150.38M |
| Accumulated Other Comprehensive Income | -371.18K |
| Shareholders Equity | 49.40M |
| Shareholders Equity (USD) | 49.40M |
| Liabilities Non-Current | 77.26K |
| Trade and Non-Trade Payables | 1.79M |
| Cash Flow |
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.39M |
| Net Cash Flow from Operations | -10.39M |
| Share Based Compensation | 408.89K |